Evidence map›Paper›PMID 26755579›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.

Matthew W Buczynski, Melissa A Herman, Ku-Lung Hsu, Luis A Natividad, Cristina Irimia, Ilham Y Polis, Holly Pugh, Jae Won Chang, Micah J Niphakis, Benjamin F Cravatt and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Druggable Targets in Endocannabinoid Signaling.Advances in experimental medicine and biology · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Matthew W BuczynskiCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037;
Melissa A HermanCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037;
Ku-Lung HsuThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.ORCID http://orcid.org/0000-0001-5620-3972
Luis A NatividadCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037;
Cristina IrimiaCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037;
Ilham Y PolisCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037;
Holly PughDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.
Jae Won ChangThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.
Micah J NiphakisThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.
Benjamin F CravattThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.
Marisa RobertoCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037;
Loren H ParsonsCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037; lparsons@scripps.edu.
Scripps Research Institute · US

Funding

UHTS Implementation(Florida)U54MH084512 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI ROSEN, HUGH · 2008 to 2013
$89.2M
Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ERIC P ZORRILLA · 2003 to 2026
$46.3M
Electrophysiology of alcohol in extended amygdelaU01AA013498 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 2001 to 2026
$12.6M
SYNTHESIS OF SR141716A AND ANANDAMIDE ANALOGSP01DA009789 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI LICHTMAN, ARON H · 1995 to 2013
$11.6M
SYSTEMIC NEUROPHARMACOLOGYP50AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE · PI KOOB, GEORGE F · 1985 to 2002
$5.1M
CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENTR01DA033760 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F, SCAMPAVIA, LOUIS DANIEL · 2012 to 2021
$5.1M
Regulation of Ethanol Effects on Synaptic TransmissionR01AA015566 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2006 to 2019
$4.6M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR37AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2016 to 2025
$3.7M
Alcohol dependence and brain endocannabinoid functionR01AA020404 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARTIN-FARDON, REMI · 2011 to 2015
$2.2M
Functional Characterization of Diacylglycerol Lipases in Mammalian PhysiologyR00DA035864 · NIDA · UNIVERSITY OF VIRGINIA · PI HSU, KU-LUNG · 2015 to 2017
$744k
The role of the OEA synthase NAPE-PLD in nicotine signaling and rewardK99DA035865 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI BUCZYNSKI, MATTHEW WALLACE · 2014 to 2015
$284k
Effect of nicotine self-administration on endocannabinoids & related lipidsF32DA029994 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI BUCZYNSKI, MATTHEW WALLACE · 2011 to 2013
$161k
NIAAA NIH HHS F32 AA020430NIAAA NIH HHS P50 AA006420NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA013498NIAAA NIH HHS R01 AA015566NIAAA NIH HHS R01 AA020404NIAAA NIH HHS R01AA020404NIAAA NIH HHS R37 AA017447NIAAA NIH HHS U01 AA013498NIDA NIH HHS F32 DA029994NIDA NIH HHS K99 DA035864NIDA NIH HHS K99 DA035865NIDA NIH HHS P01 DA009789NIDA NIH HHS R00 DA035864NIDA NIH HHS R01 DA009789NIDA NIH HHS R01 DA033760NIMH NIH HHS R01 MH084512NIMH NIH HHS U54 MH084512
6 · The paper itself

Abstract

Chronic nicotine exposure (CNE) alters synaptic transmission in the ventral tegmental area (VTA) in a manner that enhances dopaminergic signaling and promotes nicotine use. The present experiments identify a correlation between enhanced production of the endogenous cannabinoid 2-arachidonoylglycerol (2-AG) and diminished release of the inhibitory neurotransmitter GABA in the VTA following CNE. To study the functional role of on-demand 2-AG signaling in GABAergic synapses, we used 1,2,3-triazole urea compounds to selectively inhibit 2-AG biosynthesis by diacylglycerol lipase (DAGL). The potency and selectivity of these inhibitors were established in rats in vitro (rat brain proteome), ex vivo (brain slices), and in vivo (intracerebroventricular administration) using activity-based protein profiling and targeted metabolomics analyses. Inhibition of DAGL (2-AG biosynthesis) rescues nicotine-induced VTA GABA signaling following CNE. Conversely, enhancement of 2-AG signaling in naïve rats by inhibiting 2-AG degradation recapitulates the loss of nicotine-induced GABA signaling evident following CNE. DAGL inhibition reduces nicotine self-administration without disrupting operant responding for a nondrug reinforcer or motor activity. Collectively, these findings provide a detailed characterization of selective inhibitors of rat brain DAGL and demonstrate that excessive 2-AG signaling contributes to a loss of inhibitory GABAergic constraint of VTA excitability following CNE.

Indexed as

AnimalsArachidonic AcidsEndocannabinoidsgamma-Aminobutyric AcidGlyceridesLipoprotein LipaseMaleNicotineRatsRats, WistarSelf AdministrationVentral Tegmental AreaArachidonic AcidsEndocannabinoidsgamma-Aminobutyric AcidGlyceridesglyceryl 2-arachidonateLipoprotein LipaseNicotine2-arachidonoylglyceroldiacylglycerol lipaseGABAnicotineventral tegmental area

Identifiers

PMID26755579
PMCPMC4743781
OpenAlexW2235369907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.